ArticleTherapeutic advances in chronic disease2023

Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study.

Ye Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.